Dennis Akkaya currently fulfills the role of corporate development at myTomorrows. After experiencing losses of several close family members and some very dear friends, Dennis decided to use all his knowledge in life-science -Pharma and finance to the world of helping getting patients getting...
Simone Boselli joined EURORDIS in April 2017 as a Public Affairs Director.
A member of the European and International Advocacy team, Simone contributes to European policy development and specifically represents EURORDIS in policy discussions on access to therapies, with a focus on reducing...
Gorana Capkun, Head Rwe Enablement, Novartis Oncology
Jean-Philippe Combal, Co-Founder And Chief Executive Officer, Vivet Therapeutics
Eric Michael David, Chief Executive Officer, BridgeBio-Gene Therapy
Matt Eagles, Head of Patient Engagement, Havas Lynx
Karen Facey, Senior Research Fellow, University of Edinburgh
Geoff Fatzinger, Mging Director, CCPS UK, & Global VP of Quality, Regulatory & Strategic Services, Caligor Coghlan Pharma Services
Carlo Incerti, Operating Partner, Forbion
Javier Jimenez, EVP RWE & Late Phase, Syneos Health
Tjarda Kasteel, Country Cluster Lead Nordics & Benelux, bluebird bio
Robin Kenselaar, Senior Vice President And General Manager EMEA, Orchard Therapeutics
Diane Kleinermans, Advisor To The Ministry Of Health And Social Affairs, Belgian Federal Government
Neil Mulcock, Vice President Government Affairs And Policy, Gilead Sciences
Tobias Polak, Lead Real-World Data, myTomorrows
Frederic Revah, Chief Executive Officer, Genethon
Christopher M de M Rudolf, CEO, volv global
David Schwicker, Principal, Founder, ORPHA Strategy Consulting
Sheela Upadhyaya, Associate Director Highly Specialised Technologies, National Institute for Health and Care Excellence
Sheela Upadhyaya, Special adviser, FIPRA
Martine Zimmermann, Global Head Of Regulatory Affairs, Alexion Pharmaceuticals
Martine Zimmermann PharmD. is the Senior Vice President and Head of Global Regulatory Affairs at Alexion Pharmaceuticals. Based in Zurich, she has over 20 years of combined R&D and global regulatory strategy experience. She joined Alexion in 2009 and since then has been ...